Transfer of engineered biophysical properties between different antibody formats and expression systems by Schaefer, Jonas V. & Plückthun, Andreas
Transfer of engineered biophysical properties between
different antibody formats and expression systems
Jonas V. Schaefer and Andreas Plu¨ckthun1
Department of Biochemistry, University of Zurich, Winterthurerstrasse 190,
CH-8057 Zurich, Switzerland
1To whom correspondence should be addressed.
E-mail: plueckthun@bioc.uzh.ch
Received March 7, 2012; revised May 16, 2012;
accepted May 21, 2012
Recombinant antibodies and their derivatives are receiving
ever increasing attention for many applications.
Nevertheless, they differ widely in biophysical properties,
from stable monomers to metastable aggregation-prone
mixtures of oligomers. Previous work from our laboratory
presented the combination of structure-based analysis with
family consensus alignments as being able to improve the
properties of immunoglobulin variable domains. We had
identified a series of mutations in the variable domains
that greatly influenced both the stability and the expression
level of single-chain Fv (scFv) fragments produced in the
periplasm of Escherichia coli. We now investigated
whether these effects are transferable to Fab fragments
and immunoglobulin G (IgG) produced in bacteria, Pichia
pastoris, and mammalian cells. Taken together, our data
indicate that engineered mutations can increase functional
expression levels only for periplasmic expression in pro-
karyotes. In contrast, stability against thermal and de-
naturant-induced unfolding is improved by the same
mutations in all formats tested, including scFv, Fab and
IgG, independent of the expression system. The mutations
in VH also influenced the structural homogeneity of full-
length IgG, and the reducibility of the distant CH1–CL
inter-chain disulfide bond. These results confirm the poten-
tial of structure-based protein engineering in the context
of full-length IgGs and the transferability of stability
improvements discovered with smaller antibody fragments.
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Introduction
Murine monoclonal antibodies first emerged as diagnostic
and therapeutic agents in the late 1970s, but only the possi-
bility to generate recombinant human and engineered anti-
bodies by many technologies has led to their greatly
accelerated adoption for human therapy. The reliable and in-
expensive production of various antibody formats in recom-
binant form has remained one of the major objectives for
antibody engineering, as antibodies differ widely in their bio-
physical properties. Small antibody fragments like single-
chain Fv (scFv) or Fab expressed in Escherichia coli
(Huston et al., 1988; Skerra and Plu¨ckthun, 1988;
Glockshuber et al., 1990) have been pivotal research inter-
mediates in essentially all antibody engineering projects, but
by far most antibodies used in the clinic today have been
converted to the immunoglobulin G (IgG) format (Plu¨ckthun
and Moroney, 2005; An, 2010; Beck et al., 2010). The main
reason is that most clinical applications rely on the effector
function of the IgG Fc region. Even if the expression of full-
length IgG has been performed successfully in E. coli
(Simmons et al., 2002; Mazor et al., 2009; Makino et al.,
2011), therapeutic antibodies generally are produced in mam-
malian cells, as only this expression system can carry out the
posttranslational modifications and introduce the complex
glycosylation necessary for most of the functional activities
of IgG molecules.
Compared with conventional small molecules, antibody
drugs offer advantages concerning their extended half-life in
vivo and their ability for initiating host immune responses such
as antibody-dependent cellular cytotoxicity (ADCC) or
complement-dependent cytotoxicity (CDC) (Jefferis et al.,
1998). The long half-life of IgG molecules is due to the pH-
dependent binding of the CH2–CH3 interface to the neonatal re-
ceptor FcRn, a major histocompatibility complex class I-like
molecule expressed on the vascular endothelium. Binding to
FcRn protects antibodies from degradation by enabling recyc-
ling of the molecules and thereby increases their serum persist-
ence (Ghetie and Ward, 2000; Roopenian and Akilesh, 2007).
Residues located in the hinge region and the CH2 domain
contact the Fcg receptors, and among them especially the ac-
tivating FcgRIIIa is responsible for triggering ADCC by
recruiting immune cells that lead to phagocytosis or lysis of
the targeted cells (Jefferis et al., 1998; Shields et al., 2001;
Lazar et al., 2006; Strohl, 2009; Kaneko and Niwa, 2011).
The latter interaction requires the complex glycosylation
obtained from mammalian expression systems, which is not
provided by yeast and plant expression systems (Jefferis,
2009; Lux and Nimmerjahn, 2011). In CDC, antibodies acti-
vate the complement cascade at the cell surface, upon being
triggered by C1q binding to the CH2 domain—eventually
killing the targeted cells (Ricklin et al., 2010).
IgGs are composed of various domains, all of them posses-
sing the characteristic immunoglobulin fold consisting of two
antiparallel b-sheets forming a b-sandwich (Lesk and Chothia,
1982; Padlan, 1994), which can aggregate, probably involving
the b-strands, as in many aggregates of other proteins
(Dobson, 2003). The overall stability of the full-length IgG
molecule depends on both the intrinsic stabilities of the indi-
vidual domains as well as on the stability of the corresponding
interfaces (Brandts et al., 1989; Wo¨rn and Plu¨ckthun, 1998,
1999; Ro¨thlisberger et al., 2005). The various IgG domains are
known to feature intrinsic differences in their conformational
stability and therefore might also be responsible to different
degrees for the biophysical properties of the antibody as a
whole.
The IgG’s antigen-binding sites are formed by the comple-
mentarity determining regions (CDRs) within the N-terminal
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variable regions of both the light chain (VL) and heavy chain
(VH) coming together and generating the unique surface that
specifically recognizes and binds the corresponding antigens
(Mian et al., 1991). The remaining framework of the variable
domains is quite conserved in both sequence and structure.
Neveretheless, different families of variable domains with
varying framework sequences have shown quite distinct bio-
physical properties (see below). The particular arrangement
of the antigen-binding region within the CDRs thus permits
re-engineering of the framework residues without jeopardiz-
ing antigen binding, at least to a first approximation.
Owing to the great sequence diversity within their variable
regions, antibodies show a wide range of biophysical proper-
ties (Ewert et al., 2003b; Garber and Demarest, 2007; Wang
et al., 2009). Favorable properties are important for a number
of reasons (Demarest and Glaser, 2008). First, an aggregation-
prone molecule would run the danger of leading to unspecific
binding in vivo, premature clearance, loss of clinical efficacy
and the danger of eliciting a T-cell-independent immune re-
sponse (Maas et al., 2007; Singh et al., 2010). Second, the
aggregation-tendency would be potentiated in fusion proteins
with additional aggregation-prone domains or multimerized
constructs, rendering many antibody fusions impossible to be
produced efficiently. Finally, low stability and a tendency to
aggregate will decrease the expression level, and may thus
make otherwise promising molecules economically not viable.
In previous work (Ewert et al., 2003b), we discovered sur-
prising differences in the biophysical properties of the germ-
line families of human VH domains, as well as both human
domains encoding the k and l light chain (Vk and Vl), re-
spectively. By sequence comparison of the human consensus
VH domains, particular mutations could be identified
(Fig. 1a) that proved to be responsible for the favorable bio-
physical properties of families 1, 3 and 5, as well as for the
less favorable properties of families 2, 4 and 6. Subsequently,
these sequence differences were transplanted from a VH3
consensus framework to the very poorly stable and poorly
expressing VH6 framework (Ewert et al., 2003a). In brief,
two non-glycine residues with positive f angles in the
Ramachandran plot were converted to glycines (positions 16
and 76; numbering scheme according to Honegger and
Plu¨ckthun, 2001), inducing a positive effect on both thermo-
dynamic stability and functional expression in E. coli. As
functional periplasmic expression levels are limited by
folding (Ewert et al., 2003b), they constitute an excellent
measure of aggregation during in vivo folding. In addition,
Fig. 1. Alignment of VH sequences. (a) Comparison of HuCAL-derived WT VH3 and VH6 sequences (two uppermost sequences). The VH6 domain, having
aggregation-prone behavior and the lowest midpoint of denaturation, was brought closer to the VH3 sequence as described before (Ewert et al., 2003a), leading
to the engineered M variant (lower line). This mutant holds the following six amino acid exchanges: Q5V, S16G, T58I, V72D, S76G and S90Y. Only mutated
amino acids are highlighted and color-coded according to residue type: aromatic (orange), hydrophobic (yellow), uncharged hydrophilic residues (green) and
acidic (red). The numbering scheme is according to Honegger and Plu¨ckthun (2001). (b) Summary of the two different IgG constructs, 2C2 and 6B3, analyzed
in this study. (c) SDS-PAGE analysis of equal amounts of the Protein A-purified IgG constructs under reducing conditions, stained with Coomassie Blue.
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two residues with non-optimal b-strand forming features
were exchanged to amino acids possessing higher b-sheet
propensity (Q5V and S90Y), both affecting functional expres-
sion, but only the first having a significant thermodynamic
equilibrium effect. The removal of a buried
non-hydrogen-bonded OH group (T58I) led to a very large
increase in thermodynamic stability, but no effect on folding
yield. Conversely, the mutation of a solvent-exposed hydro-
phobic residue to a hydrophilic one (V72D) increased the
in vivo folding yield but had very little effect on thermo-
dynamic stability.
All the selected mutations (Q5V, S16G, T58I, V72D,
S76G and S90Y) were located within the VH framework and
not in the CDRs, as these mutations were intended to be as
generally applicable as possible and unlikely to affect
antigen binding. As intended, the combined mutations con-
ferred properties almost identical to the favorable VH3 frame-
work on the VH6 framework (Ewert et al., 2003a), which
afterwards experienced a dramatic increase in both expres-
sion yield and thermodynamic stability without having
altered binding properties.
These data were recorded for two model antibody scFvs
named 2C2 and 6B3 that had originally been selected from
the HuCAL library (Knappik et al., 2000) by panning against
the peptide M18 coupled to transferrin or myoglobin from
horse skeletal muscle, respectively. We chose these mole-
cules as both are representatives of the human VH6 frame-
work family whose members are known to have a rather
aggregation-prone behavior and the lowest thermodynamic
stability of all human VH domains (Ewert et al., 2003b). 2C2
and 6B3 have different CDR-H3 loops, while otherwise their
VH sequence is identical. In addition, the two antibodies
(compared in Fig. 1b) differ in their respective light chain,
with 2C2 having a Vk3 and 6B3 containing a Vl3 light
chain. Importantly, the previously detected improvements
were independent of both the VL domain as well as the se-
quence and length of the CDR-H3, as both constructs gave
similar results (Ewert et al., 2003a).
These improvements had been uncovered and investigated
with antibody constructs small enough to untangle the contri-
butions of the individual domains with spectroscopic investi-
gations, using scFv constructs which consist of just two
domains. However, the question arose, whether the rather
dramatic effects of these mutations might somehow be dam-
pened in a larger assembly, such as a whole IgG, and
whether the eukaryotic secretory quality control (Anelli and
Sitia, 2008) might overcome all folding issues seen in
E. coli. Thus, we now tested the influence of these well-
characterized mutations in the context of full-length human
IgG1 or Fab molecules expressed in eukaryotic systems.
Both the wild-type (WT) and best engineered variant (carry-
ing all six mutations described above, called ‘M’ for
‘mutant’ in this study) were converted to the Fab or full-
length IgG format and investigated for their biophysical
properties and expression characteristics upon production in
human embryonic kidney (HEK) 293 cells and the yeast
Pichia pastoris (PP). After Protein A purification, these
molecules show the expected running behavior in reducing
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS PAGE) (Fig. 1c).
To be able to carry out such studies with whole IgGs or
Fab fragments, eukaryotic expression systems were required
where functional expression yields would exclusively depend
on the protein sequence. Therefore, these systems must rely
both on homologous recombination to exactly the same locus
and on constitutive expression to eliminate complication
from the induction strategy. For Fab and IgG production in
HEK293 cells, stable cell lines were created using the Flp-In
system (Invitrogen). These cell lines expressed and secreted
the antibody constructs under control of the constitutive cyto-
megalovirus (CMV) promoter in sufficient amounts, allowing
the purification and subsequent biophysical analysis of these
proteins. As Pichia does not maintain episomal vectors, ex-
pression cassettes were anyway designed for integration into
the yeast genome. To ensure a comparable expression setup
between mutants, the constitutive GAP promoter was used.
In this study, we compare the effects of the previously
described mutations on the biophysical properties of anti-
bodies in the IgG and Fab format, produced in mammalian
and yeast cells, using a wide array of biophysical techniques.
We also analyze the effect of the mutations on the expression
levels in bacteria, yeast and mammalian cells—allowing a
differentiation of how the various cellular hosts deal with
aggregation-prone proteins in general.
Materials and methods
Cell culture
Materials and cultivation of mammalian and Pichia
cells. All media and supplements for mammalian expression
were purchased either from Sigma-Aldrich (MO, USA),
Invitrogen (CA, USA) or Amimed (BioConcept, Switzerland).
The antibiotics ZeocinTM and Hygromycin B were bought
from Invitrogen or PAA (Austria), respectively. All solutions
used were either delivered sterile or sterilized by filtration
through 0.22 mm filters (Millipore, MA, USA). Stably trans-
formed HEK293 cells were maintained in Dulbecco’s modi-
fied Eagle medium (DMEM; Sigma-Aldrich; high glucose:
4.5 g/l) supplemented with 10% v/v heat-inactivated fetal
bovine serum (FBS; Amimed) in a humidified incubator with
5% carbon dioxide at 378C. Expression of IgGs was carried
out in DMEM supplemented with 5% v/v FBS (instead of the
more commonly used 10%). For secretion of IgGs, derivatives
of the vector pcDNA5 (Invitrogen) containing constitutively
active CMV promoters upstream of the native IgG signal
sequences were used (see below).
For all work with Pichia, the strain SMD1163 (his4 pep4
prb1; Invitrogen) was used. All media and supplements for
this work were purchased either from Sigma-Aldrich or
Invitrogen. All work was done in a sterile laminar flow
bench, and yeast growth was performed at 308C. Selection of
clones stably expressing the IgGs was based on ZeocinTM re-
sistance. For secretion of IgGs, derivatives of the pGAPZaB
vector (Invitrogen) containing the constitutively active Pichia
GAP promoter followed by the a-factor pre-pro (aMFpp)
region were used. Yeast extract-peptone-dextrose (YPD)
medium containing 20 g/l peptone, 10 g/l yeast extract and
20 g/l D-glucose (plus 20 g/l agar for YPD-agar) was used
for routine growth and subculturing of Pichia cells.
ZeocinTM was added to a final concentration of 100 mg/ml.
IgG expression was performed in the phosphate-buffered
medium with glycerol for yeast (BMGY) (20 g/l peptone,
10 g/l yeast extract, 100 mM potassium phosphate pH 6.0,
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1.34% yeast nitrogen base (YNB) without amino acids, 1%
w/v glycerol, 400 mg/l biotin) in the absence of antibiotic.
Construction of expression plasmids. Unless stated other-
wise, all molecular biology methods were performed accord-
ing to standard protocols (Sambrook and Russell, 2001). All
enzymes used for cloning were purchased from New
England Biolabs (MA, USA) or Fermentas (Germany). In
general, cloning and propagation of all plasmids was carried
out in E. coli DH5a (Life Technologies, CA, USA), grown
at 378C in low salt LB Broth (10 g/l Bacto-tryptone, 5 g/l
yeast extract, 5 g/l NaCl, pH 7.5) containing 25 mg/ml
ZeocinTM for the Pichia plasmids or in 2YT broth (16 g/l
Bacto-tryptone, 10 g/l yeast extract, 5 g/l NaCl, pH 7.5) con-
taining 100 mg/ml Ampicillin (AppliChem, Germany) for
mammalian vectors.
The construction of expression vectors is described in
detail in the Supplementary Material. In brief, expression
vectors for mammalian HEK293 cells were derived from the
pMORPHw vector series (MorphoSys), in which heavy or
light chain are separately expressed. For the establishment of
stable cell lines using the Flp-In system (Invitrogen), the two
expression cassettes for H and L, each retaining its own pro-
moter and poly-A sequence, were combined into a single
vector based on the pcDNA5/FRT series (Invitrogen). The
creation of Fab expression vectors was performed likewise,
in this case, however, the VH/CH1 chain was fused to a
myc-tag and (his)6-tag at its C-terminus for detection and
purification purposes.
The Pichia expression vectors are based on the vector
pGAPZaB (Invitrogen). The sequences for the light chains
and the different heavy-chain variants were amplified from
the pMORPHw vectors and thus placed behind the a-factor
pre–pro (aMFpp) sequence and under the control of the con-
stitutive GAP promoter. Before stable integration into the
Pichia genome, the two expression cassettes for H and L,
each retaining its own promoter and termination sequence,
were combined onto one plasmid.
Construction of glycan knock-out mutants T299A. To
analyze the influence of the glycan moiety attached to
Asn297 in the CH2 domain of the heavy chains, the glycan
knock-out construct T299A was constructed, described in
detail elsewhere (Schaefer and Plu¨ckthun, 2012). In brief,
ACG coding for the threonine in the glycosylation motif
Asn297-Ser298-Thr299, was mutated to alanine-encoding GCG
using the QuikChangew site-directed mutagenesis kit from
Stratagene (acquired by Agilent, USA) according to the man-
ufacturer’s instructions.
Creation of stable cell lines. Flp-In HEK293 cell lines
(Invitrogen), stably expressing the IgG of interest and secret-
ing it into the culture medium, were generated according to
the instructions of the Flp-In system manual. For this
purpose, the expression cassettes for both the heavy- and
light-chain genes were cloned into the pcDNA5/FRT vector
and finally inserted at a specific location in the genome by
the Flp recombinase within the cell. After selection, 10
single clones of each construct were tested for expression of
the desired IgG by western blot analysis of the supernatant.
More than 90% of the analyzed clones were positive.
For the Pichia constructs, the corresponding plasmids con-
taining both genes for the light and heavy chain under the
control of constitutively active GAP promoters within one
plasmid were linearized by BglII and integrated into the
yeast genome upon transformation of competent Pichia
(Cregg et al., 2009). Finally, several colonies per construct
were re-plated on fresh YPD-agar plates containing
ZeocinTM and subsequently analyzed for IgG expression by
western blot.
Expression of IgG. Large-scale expression in the mammalian
and the yeast system is described in detail elsewhere
(Schaefer and Plu¨ckthun, 2012). Prokaryotic expression of
IgG was performed in E. coli SB536 (WG1 DfhuA DhhoAB
(Bass et al., 1996)) in small scale. Both chains were placed
in a bicistronic ORF within pMORPHwX7 derivatives
(MorphoSys; (Cesaro-Tadic et al., 2003)) under an inducible
lac promoter/operator. Pre-cultures of 5 ml 2YT medium
containing 1% glucose were inoculated with a single colony
and incubated at 378C overnight. The expression cultures
(10 ml 2YT with 0.1% glucose) were inoculated with the
pre-cultures at an OD600 of 0.1 and grown at 308C for 20 h.
IgG synthesis was not actively induced by adding inducer
but rather driven from the leaky expression once all glucose
was consumed. IPTG addition only marginally increased the
amount of full-length IgG but lead to more partially
assembled molecules (like HL and H2L intermediates). The
next day, the cultures were OD-normalized and molecules in
the periplasmic space were extracted by incubation of the
cell pellet for 2 h at 48C in the presence of 200 mM boric
acid, 160 mM NaCl, 2 mM ethylenediaminetetraacetic acid
(EDTA), pH 8.0. Finally, the expression levels of WT and M
variants were compared by western blots using anti-light
chain-specific antibodies as described below.
Biophysical and biochemical analysis
Purification of IgGs. Antibodies were purified from culture
supernatants by Protein A affinity chromatography. For this
purpose, the supernatants were loaded onto HiTrap Protein
A columns (GE Healthcare, USA) at 48C at a flow rate of
1 ml/min. Chromatography was performed using an A¨KTA
PrimePlus chromatography system (GE Healthcare) at 48C.
After loading, the column was washed with 100 mM sodium
phosphate buffer pH 8.0 containing 150 mM NaCl. Elution
of IgG was accomplished by using 0.1 M glycine pH 2.7,
followed by immediate neutralization of each fraction to pH
7.5 using 1 M Tris, pH 8.0. The concentrations of the sample
fractions were determined by UV-spectroscopy at 280 nm
with a NanoDrop ND-1000 spectrophotometer (Thermo
Scientific), assuming a mass extinction coefficient of 1.37
for a 1 mg/ml solution of IgG. The samples with the highest
protein concentration were pooled and dialyzed twice against
phosphate buffered saline (PBS; Sigma-Aldrich; 10 mM
Na2HPO4, 1.8 mM KH2PO4, 2.7 mM KCl, 137 mM NaCl,
pH 7.1) at 48C. After dialysis, the samples were filtered
through 0.22-mm filters (Millipore) and stored at 48C.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
and western blotting. Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) was per-
formed using either NuPAGE precasted 4–12% gradient gels
(Invitrogen) according the manufacturer’s instructions or
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self-made Tris-glycine 7.5% or 12% gels for non-reduced or
reduced samples, respectively. Gels and samples were pre-
pared according to standard protocols (Laemmli, 1970) and
1.5 mg of IgG antibody was loaded per lane. Non-reduced
samples were only mixed with loading buffer, while for
reduced samples dithiothreitol (DTT) was added to a final
concentration of 16 mM, followed by incubation for 5 min at
958C. As molecular mass marker the PageRuler prestained
protein ladder (Fermentas) was used. The gels were stained
using Coomassie following standard protocols or by silver
staining according to the manufacturer’s instructions
(Invitrogen).
For the specific detection of the IgGs, the proteins were
transferred to a polyvinylidene difluoride membrane
(Millipore) after their separation by SDS-PAGE. Blotting was
performed following the semi-dry method within a Trans-Blot
SD cell (Bio-Rad, CA, USA) for 60 min at 11 V, using a
Tris–glycine buffer (20 mM Tris, 150 mM glycine, 10%
methanol). After blocking the membrane in 5% MPBST (5%
w/v skimmed milk dissolved in PBST (PBS with 0.05%
Tween-20)) for at least 1 h, the membrane was incubated for
another hour in 2.5% MPBST containing the appropriate de-
tection antibody conjugated to alkaline phosphatase. For de-
tection of the light chains, an anti-human lambda-light
chain-specific antibody (Sigma-Aldrich, #A2904; 1 : 1500 di-
lution) or an anti-human k-light chain-specific antibody
(Southern Biotech, #2060-04; 1 : 3000 dilution) were used.
Bands were detected by the addition of NBT-BCIP solution
(nitro-blue tetrazolium chloride with 5-bromo-4-chloro-30-
indolyphosphate p-toluidine salt; Sigma-Aldrich) in 100 mM
Tris pH 9.5, 5 mM MgCl2, 100 mM NaCl. The development
was terminated when the first bands became clearly visible by
rinsing the membrane in ultra high pure water.
Isoelectric focusing. Determination of the isoelectric point
(pI) of the constructs was carried out in isoelectric focusing
(IEF) Ready Gels (pH 5–8; Bio-Rad) according to the man-
ufacturer’s instructions on a Mini-PROTEAN II vertical cell
system (Bio-Rad), using increasing voltages (100 V for 1 h,
250 V for 1 h, and 500 V for 30 min). Next to the samples,
an IEF standard (Bio-Rad) was co-electrophoresed. The
cathode and anode buffers were 20 mM lysine/20 mM argin-
ine or 7 mM phosphoric acid, respectively. Following elec-
trophoresis, the proteins were visualized by Coomassie
Blue—Crocein Scarlet staining (0.04% w:v Coomassie
R-250 and 0.05% w:v Crocein Scarlet 3B in 27% isopropa-
nol/10% acetic acid) for 45 min and destaining (40% metha-
nol/10% acetic acid).
Capillary electrophoresis. Capillary electrophoresis was per-
formed on the chip-based Lab-Chip 90 instrument (Caliper
Life Sciences, MA, USA) under non-reducing and reducing
conditions following the manufacturer’s instructions with
slight modifications. In brief, 5 ml sample containing 2.5 mg
IgG was mixed with 35 ml of denaturation solution and incu-
bated either at 258C or 758C for 5 min. The denaturation so-
lution was prepared according to the provided protocol either
without any reducing agent or by the addition of DTT in the
recommended concentration. Seventy microliters of distilled
water were added to each sample prior to analysis and the
analysis chip was primed according to the manufacturer’s
instructions. The automated protein analysis generated both a
chromatogram (showing migration time) as well as a virtual
gel (mimicking a Coomassie-stained gel) as output.
2D-electrophoresis with SDS-PAGE in both dimensions. To
analyze whether the different banding patterns in WT and M
samples consist of species which can be separated or species
which re-equilibrate, a 2D-SDS-PAGE was devised. Gels
were run in a cold room. Duplicates of 4 mg IgG samples
were run for the first dimension on an SDS-PAGE gel on
two identical halves. While one half of the gel (containing
one of the duplicates each) was used for Coomassie staining
of the protein bands, the second half was stored temporarily
in SDS-running buffer. After the bands were clearly visible,
either the corresponding positions or whole lanes on the un-
stained gel half were cut and placed on top of the second
SDS polyacrylamide gel in perpendicular orientation. This
resulted in the re-separation based on the size of the proteins
in the second dimension as well. To prevent air bubbles to
influence the running behavior, the placed pieces of gel were
mounted with regular stacking gel material poured round the
gel pieces. The final gel was stained using the Silver Quest
kit (Invitrogen) according to the manufacturer’s instructions.
Analysis of IgG and Fab expression levels by enzyme-linked
immunosorbent assay. To analyze the influence of the per-
formed mutations on the antibody expression and secretion
levels, the same number of HEK293 cells stably expressing
the corresponding IgG or Fab constructs was seeded in
12-well plates. On reaching confluency, the medium was
removed and replaced by 1 ml expression medium, contain-
ing 5% FBS. Twenty-four hours later, the supernatant was
analyzed for its IgG or Fab content by enzyme-linked im-
munosorbent assay (ELISA). For the Pichia-produced IgGs,
OD-normalized aliquots were taken after 24 h expression for
ELISA analysis. For the IgG detection ELISA, a capture
antibody recognizing the human IgG heavy chain (Jackson
ImmunoResearch, PA, USA; #209-005-098) was immobi-
lized on MaxiSorb plates (Nunc) overnight at 48C. For detec-
tion of Fab fragments in the supernatant, an anti-myc capture
antibody (Sigma-Aldrich, #M4439; 1 : 2000 dilution) was
coated on the plates. After 1 h blocking in 5% skimmed milk
in PBST, 100 ml of Pichia or HEK-derived supernatant
(diluted in a range of 1 : 25 to 1 : 100 in fresh BMGY or
DMEM media) was incubated for 1 h at room temperature.
The expressed IgG or Fab molecules were detected by incu-
bating with an anti-human lambda-light chain-specific anti-
body conjugated to alkaline phosphatase (Sigma-Aldrich,
#A2904; 1 : 2000 dilution) for 1 h and subsequent addition of
p-nitrophenyl phosphate (Sigma-Aldrich). Absorbance at
405 nm was measured using a Perkin Elmer HTS 7000 Plus
plate reader by sampling up to 1 h.
To analyze the levels of IgG still present within the cells,
cells stably expressing the IgG constructs were cultured in
12-well plates for 3 days in duplicates. The supernatant was
harvested, the cells washed twice with PBS and finally
250 ml of radioimmunoprecipitation assay buffer (50 mM
Tris pH 7.5, 150 mM NaCl, 1% NP40 and 0.25%
Na-deoxycholate) added to the cells before the plates were
placed at 2808C for 2 h. After this freezing-thawing step,
the cells were scraped off and the extracts were subsequently
analyzed by SDS-PAGE followed by Coomassie staining or
by western blotting. To allow the simultaneous detection of
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IgG in the supernatant and the cellular extracts on the same
gel, only 1/6 of the corresponding supernatant was loaded
compared with the cellular extract, and all samples were
heated to 958C for 5 min prior to loading.
Circular dichroism spectroscopy. Circular dichroism (CD)
measurements were performed on a Jasco J-810
Spectropolarimeter (Jasco, Japan) equipped with a computer-
controlled water bath (refrigerated circulator FS18, Julabo,
Germany), using a 0.5-mm cylindrical thermocuvette. CD
spectra were recorded from 200 to 250 nm with a data pitch of
0.5 nm, a scan speed of 20 nm/min, a response time of 4 s,
and a bandwidth of 2 nm. Measurements were performed at
258C and each spectrum was recorded three times and aver-
aged. The CD signal was corrected by buffer subtraction and
converted to mean residue ellipticity (MRE) using the concen-
tration of the sample determined spectrophotometrically at
280 nm. Heat denaturation curves were obtained by measuring
the CD signal at 208 nm at temperatures increasing from 258C
to 908C (heating rate 18C/min; response time 4 s; bandwidth
2 nm). Data were collected and processed as described above.
CD spectra and denaturation curves of the purified IgGs were
measured in PBS (Sigma-Aldrich; pH 7.1) at a protein con-
centration of 5 mM.
Intrinsic tryptophan fluorescence. Intrinsic tryptophan fluor-
escence (ITF) was measured with a Jobin-Yvon Fluoromax-4
spectrofluorimeter (Horiba Scientific, NJ, USA) equipped
with a Peltier-controlled cuvette holder. The temperature was
controlled by an LFI3751 5A digital temperature control in-
strument (Wavelength Electronics Inc., MT, USA). Upon ex-
citation at 295 nm, Trp emission spectra were recorded from
300 to 400 nm (Dl ¼ 1 nm, scan rate 1 nm/s) in 0.58C steps
from 258C to 908C. The sample cuvette was equilibrated for
2 min at each temperature to ensure that the desired tempera-
ture was reached within the cell. Protein concentrations were
1 mM in every case, and all measurements were performed
in PBS (pH 7.1). The intensity of the emission spectrum at
330 nm (F330) and 350 nm (F350) was determined at each
temperature, the ratio F330/F350 calculated and subsequently
plotted as a function of temperature.
For the analysis of the midpoints of denaturation at
various pH, IgGs were dialyzed overnight and analyzed at
the conditions described above in the following buffers. For
pH 4 and 5: 25 mM sodium acetate, 130 mM NaCl; for pH
6, 7 and 8: 25 mM sodium phosphate, 130 mM NaCl; for pH
9 and 10: 25 mM sodium carbonate, 130 mM NaCl.
Guanidine hydrochloride-induced equilibrium unfolding.
Guanidine hydrochloride (GdnHCl)-induced denaturation
measurements were carried out with protein/GdnHCl mix-
tures containing a final protein concentration of 1 mM and
denaturant concentrations ranging from 0 to 5 M (99.5%
purity; Fluka, MO, USA). These mixtures were prepared
from a 6 M GdnHCl stock solution (in PBS, pH adjusted to
7.1) and equilibrated overnight at 258C. Each final concentra-
tion of GdnHCl was determined by measuring the refractive
index. The intrinsic fluorescence emission spectra were then
recorded from 300 to 400 nm with an excitation wavelength
of 295 nm in an Infinite M1000 reader (Tecan, NC, USA).
Individual GdnHCl blanks were recorded and automatically
subtracted from the data. The emission ratio F330/F350 was
calculated and plotted as a function of GdnHCl concentra-
tion. Time-dependent unfolding was recorded with the same
setup in a Jobin-Yvon Fluoromax-4 spectrofluorimeter
(Horiba Scientific, NJ, USA), recording full spectra every
2 min for 5.5 h, starting at the time of GdnHCl addition
without any previous incubation.
Size-exclusion chromatography. Size-exclusion chromatog-
raphy (SEC) experiments were performed using a Superdex
200 PC 3.2/30 column (GE Healthcare). The runs were per-
formed in PBS buffer (Sigma-Aldrich, pH 7.1) at a flow rate
of 0.06 ml/min at 258C on an A¨KTA Micro system (GE
Healthcare). Samples of 50 ml containing 6.7 mM IgG were
injected and protein elution was monitored at 280 nm.
Cytochrome c (12.4 kDa), albumin (66 kDa) and b-amylase
(200 kDa) were used as standards to calibrate the column.
Reverse phase-high-performance liquid chromatography
analysis. High-performance liquid chromatography (HPLC)
analyses were performed according to Dillon et al. (2006) on
an Agilent 1100 HPLC system equipped with a binary pump.
Samples were separated on a Zorbax SB300 C8, 3.5 mm at
758C with a flow rate of 0.25 ml/min. The following setup
was used for all runs: solvent A: 0.1% TFA, solvent B:
0.09% TFA/9.9% water/20% acetonitrile/70% isopropanol.
The column was initially equilibrated with 90% mobile
phase A and 10% mobile phase B for 5 min followed by a
2-min step gradient from 10 to 25% B. Elution was achieved
with a linear gradient of 25–40% B over 18 min. Afterwards
a final flush of 90% B was performed for 5 min and the
system set back to initial conditions and equilibration for
11 min prior to the next run (total run time ¼ 45 min).
Reduced samples were adjusted to 4.2 M GdnHCl/70 mM
Tris/3.5 mM EDTA, pH 8.6 in the presence of 50 mM DTT
and incubated at room temperature for 2 h prior to analysis.
Cation-exchange chromatography. Cation-exchange chroma-
tography (CIEX) was carried out on an Agilent 1100 binary
pump LC system equipped with a TSKgel CM-STAT
column, 7 mm, 4.6  100 mm column (Tosoh Bioscience,
Japan). Thirty micrograms of purified IgGs were injected
onto the column equilibrated in buffer A (25 mM sodium
phosphate pH 6.0). Antibodies were eluted by a linear gradi-
ent to 30% buffer B (25 mM sodium phosphate pH 6.0, 1 M
sodium chloride) over a 30-min time period with detection at
280 nm. The column temperature and flow rate were main-
tained at 258C and 0.5 ml/min, respectively.
Differential scanning calorimetry. Differential scanning cal-
orimetry (DSC) measurements were performed using a
VP-Capillary DSC system (Microcal Inc., acquired by GE
Healthcare). The antibody concentrations were adjusted to
0.5 mg/ml prior to the measurement. The corresponding
buffer was used as a reference. The samples were heated from
158C to 1008C at a rate of 18C/min after initial 8 min of
equilibration at 158C. A filtering period of 10 s was used and
data were analyzed using Origin 7.0 software (OriginLab
Corporation, MA, USA). Thermograms were corrected by
subtraction of buffer-only scans and then normalized to the
molar concentration of the protein. The final excess heat-
capacity thermogram was obtained by interpolating a cubic
baseline in the transition region. The midpoint of a thermal
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transition temperature (Tm) was obtained by analyzing the
data using Origin 7 software provided with the instrument. As
all measured transitions are irreversible, all the experimental
values reported in this study for melting temperatures have to
be regarded as ‘apparent’ values.
Differential-scanning fluorimetry. Differential scanning
fluorimetry (DSF) was performed using the Rotor-Gene Q
real-time PCR cycler (QIAGEN) and fluorescence data were
collected using the instrument’s HRM channel settings (lex
460 nm; lem 510 nm). The SYPRO Orange dye (Molecular
Probes; see Volkova et al. (2007) for a partial structure) in
dimethyl sulfoxide was diluted 500-fold from the supplied
stock solution into the appropriate buffers just prior to being
added to the protein solutions. The samples with a final
protein concentration of 3.5 mM in 20 ml reaction mixture
were subjected to a temperature ramp from 308C to 908C at a
heating rate of 18C/min and at 0.58C increments with an
equilibration time of 30 s at each temperature prior to meas-
urement. The Tm was determined as the temperature corre-
sponding to the maximum value of the first derivative of the
fluorescence changes, calculated by the software. When mul-
tiple unfolding transitions were observed, only the Tm value
of the first transition could be accurately determined, as the
transitions at higher temperatures overlap. Prior to the DSF
analysis, several IgGs were analyzed by fluorescence spec-
troscopy in the presence or absence of SYPRO Orange. In
agreement with the literature, the dye did not induce any
changes in the thermal stability determined by ITF, as
long as the final dye concentration was lower than a 1 : 200
to 1 : 500-fold dilution of the original reagent.
Microscale thermophoresis measurements. Binding affinities
of purified IgGs to their antigen myoglobin (Sigma-Aldrich) or
M18-Transferin (Jerini GmbH, Germany), respectively, were
measured using microscale thermophoresis (NanoTemper,
Germany) as described previously (Wienken et al., 2010).
Myoglobin or M18-Transferin was fluorescently labeled
according to the manufacturer’s instructions with a reactive
NT-647 dye using N-hydroxysuccinimide ester-chemistry
which reacts with primary amines to form dye–protein conju-
gates. For each analyzed construct, a titration series with con-
stant antigen concentration (20 mM) and varying IgG
concentrations between 10211 and 1025 M was prepared in
PBS. The mixed samples were equilibrated for 1 h at room
temperature and 4 ml of each sample was loaded in the capil-
lary. An infrared laser diode within the Monolith NT.115
instrument (NanoTemper, Germany) was used to increase the
temperature by 4 K in the beam center. Throughout the meas-
urement, the fluorescence inside the capillary was recorded by
a CCD camera and the normalized fluorescence was plotted
afterwards against the IgG concentrations. The KD values were
subsequently obtained from fitting the binding curves using
Prism 5 (GraphPad, CA, USA).
Partial reduction. Partial reduction of IgGs was performed by
incubating the samples in 30 mM tris(2-carboxyethyl)
phosphine (TCEP) for 10 min at 258C. Afterwards, the
samples were analyzed without further heating by non-
reducing SDS-PAGE and either stained by Coomassie or ana-
lyzed by western blot.
Fluorescent labeling of free sulfhydryls with 5-
iodoacetamidofluorescein (5-IAF; Thermo Fischer) was per-
formed after incubation of IgG with low mM concentrations
of TCEP (corresponding to 2–10 molar equivalents; higher
concentrations interfered with the subsequent 5-IAF coup-
ling) for 1 h at room temperature. Afterwards the partially
reduced samples were incubated with 5-fold molar excess of
5-IAF for 2 h at room temperature protected from light.
Afterwards the samples were separated by non-reducing or
reducing SDS-PAGE and the fluorescently labeled bands
detected using the LAS3000 chemiluminescence detection
system (Fuji, Japan). Finally, all protein bands were visua-
lized by Coomassie staining.
Results
Expression levels of engineered Fab and IgG formats
We first analyzed the secretion levels of correctly assembled
antibodies in the Fab and IgG format by ELISA (depicted in
Fig. 2). To compare the improvements caused by the muta-
tions, the expression yields are normalized relative to the
yield of the corresponding WT variants. Whereas for the
scFv fragments produced in E. coli the engineered M variant
previously showed an increase in yield of 4.2- or 4.3-fold re-
spectively, (Ewert et al., 2003a), (Fig. 2a), the variable
domain mutations only had a slight influence on the expres-
sion level of antibodies in eukaryotic expression systems.
Whereas for the Pichia system (Fig. 2d), the M variants still
were secreted at 15–40% increased levels, no difference
could be detected for the expression of either Fab fragments
or full-length IgGs in the HEK system (Fig. 2b and c).
To ensure that these results were not distorted by mole-
cules still trapped within the cell due to an overload of the
secretory pathway, the secreted IgG amounts were compared
with the intracellular levels (Supplementary Data Fig. S1a).
Considering that the secreted samples of each construct
loaded onto the blot were diluted 1 : 6 compared with the
corresponding intracellular fractions, the blot unambiguously
indicated that the majority of molecules were secreted for
both IgG variants. Similar results were obtained when ana-
lyzing the intracellular and extracellular IgG levels in the
Pichia system (data not shown). Interestingly, the analysis of
IgG levels secreted to the periplasm of E. coli had quite a
different outcome (Supplementary Data Fig. S1b): the com-
parison by western blot clearly showed increased expression
levels for the M variants even in the IgG format produced in
the prokaryotic system.
Analysis of biophysical properties of full-length IgG molecules
For an analysis of their biophysical properties, IgGs were
expressed either in the HEK or Pichia system in large scale
and purified by Protein A affinity chromatography. The
samples were of high purity and gave rise to the two
expected bands under reducing conditions (see Fig. 1c; the
heavy chain was detected at 50 kDa and the respective
light chains in the range of 23–27 kDa). As depicted in
Supplementary Data Fig. S2 in extracts for the HEK pro-
duced IgGs, the purified WT and M molecules behaved as
monomers in SEC but showed different elution profiles in
reverse phase HPLC (RP-HPLC) and cation CIEX. These
differences, however, could be accounted for by the
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introduced mutations themselves, influencing both the hydro-
phobicity as well as the charge of the engineered M variants.
The net hydrophobicity of the engineered M variants was
slightly increased by the two mutations Q5V and T58I, while
only being lowered by a single mutation (V72D). The ana-
lysis of reduced samples by RP-HPLC (depicted in the lower
halves of Supplementary Data Fig. S2c and S2d) clearly
indicated that the difference in the running behavior was
caused by the mutated heavy chains, as the corresponding
light chains—eluting earlier than the heavy chains due to
their lower hydrophobicity—led to identical signals for both
variants. The additional negative charge through the V72D
mutation influenced the CIEX running behavior of the engi-
neered IgG, causing the M variants to elute at higher
volumes (Supplementary Data Fig. S2e and S2f).
In addition, the binding affinity of the IgG molecules
toward their corresponding antigens was confirmed to be
fully retained (Supplementary Data Fig. S3). From micro-
scale thermophoresis measurements (Wienken et al., 2010),
the KD for the HEK IgG 2C2 was calculated to be 217+ 54
and 270+ 76 nM for the WT and M variants, respectively,
while the analogous variants for the 6B3 constructs showed
affinities of 15.7+ 4.8 and 14.5+ 3.8 nM, respectively. The
slight differences of these KD values are all within the ex-
perimental error range.
To confirm that the mutations did not influence the overall
structure of the new antibody molecules, HEK and Pichia pro-
duced IgGs were analyzed by CD. As shown in Fig. 3a and b,
the new M constructs possessed as expected the b-sheet struc-
ture typical for IgG molecules with only slight alterations. As
the signals stemming from the IgG’s b-sheets and random
coil essentially canceled out to zero at 208 nm, thermal de-
naturation of the IgG molecules was determined at this wave-
length as a function of temperature (Fig. 3c–f). The abrupt
upward jumps seen between 758C and 908C in most of the
depicted CD vs. temperature curves were caused by the for-
mation of insoluble aggregates in the respective samples.
Interestingly, the used expression system (HEK vs. Pichia)
not only caused a slightly different temperature of unfolding
onset, but, unexpectedly, also resulted in very different aggre-
gation susceptibilities of the IgGs—with the 6B3 variants
expressed in Pichia not exhibiting any detectable aggregation
at all (Fig. 3f). These effects, caused by differences in the
N-linked glycosylation and by an incomplete processing of
the a-factor pre–pro sequence at the yeast constructs, have
been studied extensively and reported elsewhere (Schaefer
and Plu¨ckthun, 2012). For this study, however, we concen-
trated on the comparison of WT and M variants. For the 2C2
construct, no significant difference in stability between WT
and M could be detected for IgGs produced in either expres-
sion system. The different signal level in Fig. 3c for the M
variant was caused by its slightly off-set curve as also
depicted in Fig. 3a. We currently do not know what causes
this offset. For the 6B3 M construct, however, increased stabi-
lities of 2.58C were seen compared with 6B3 WT expressed
in either the HEK or the Pichia system, as shown in Fig. 3d
and f.
As the method of analyzing thermal stabilities by CD
averages all changes observed over the whole IgG molecule
and thus does not allow to attribute them to particular
Fig. 2. Influence of mutations on secretion levels of antibody constructs. Secreted antibody levels of either scFv, Fab or IgG constructs detected by ELISA.
For a better comparison, the secretion yield of soluble protein is normalized relative to the yield of the corresponding WT construct. The WT constructs are
displayed in blue and the M variants in red. (a) Levels of scFv fragments found in the periplasm of E. coli (Ewert et al., 2003a). (b) Amounts of Fab
fragments secreted by stable HEK clones. (c) IgG levels found in the supernatant of stable HEK clones. (d) IgG amounts detected in the supernatant of stable
Pichia clones.
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domains, samples were further analyzed by ITF as a function
of temperature. As 70% of the tryptophan residues of the
studied IgGs are localized in the Fab fragments, this method
should be more sensitive to small changes in the stability of
these parts of the molecule. As shown in Fig. 4a and b, the
data derived from CD spectroscopy could be confirmed by ITF,
validating the increased stability of the M variants. A clear dif-
ference in stabilities could be seen for the 6B3 constructs
(Fig. 4b), where the IgG and Fab WT variants exhibited their
transition at 67.68+0.18C and 69.78+0.18C and thus at lower
temperatures compared with their engineered M counterparts
with a transition at 70.88+0.18C and 74.28+0.28C, respect-
ively. For the 2C2 constructs, the advantages of the M variants,
however, were considerably less pronounced (Fig. 4a).
To probe whether differences in the temperature-induced
unfolding of 2C2 might have been masked by intermolecular
or intramolecular aggregation, the same IgG samples were ana-
lyzed in the presence of GdnHCl. After an overnight incuba-
tion in 1 M GdnHCl before being exposed to increasing
temperature still in the presence of 1 M GdnHCl, both IgG var-
iants were clearly destabilized and started to unfold at lower
temperatures (Fig. 4c)—however, the M variant showed a
slightly increased stability of the second transition at 71.88+
0.28C, compared with its WT counterpart with 70.48+0.38C.
To finally challenge the stability of the engineered variant
with yet another parameter, the thermal stabilities of the 6B3
WT and M molecules were determined over a broad pH
range. As shown in Fig. 4d, the increased stability of the
engineered IgG proved true in all tested buffer systems
having pH values between 4 and 10. On average, the stabili-
ties of the M variants were 3.38+ 0.68C higher than those of
the corresponding WT molecules.
Fig. 3. Analysis of IgG constructs by CD. Signals derived from WT variants are displayed in blue while those of the mutant M are represented in red. (a) CD
spectra of different IgG 2C2 variants produced in mammalian cells (HEK) or in the yeast Pichia pastoris (PP), respectively. The values are reported as mean
residue ellipticity (MRE). (b) CD spectra of different IgG 6B3 variants analogous to panel (a). (c) Thermal denaturation curves of IgG 2C2 produced in
mammalian cells. The denaturation was followed by CD, plotting the signals at 208 nm as a function of temperature. The values are reported as mean residue
ellipticity. The abrupt upward jump at about 858C in the signals is caused by the formation of insoluble aggregates. (d) Thermal denaturation curves of HEK
IgG 6B3 analogous to panel (c). The temperature of aggregation onset for this construct was found to be lowered to about 758C. (e) Thermal denaturation
curves of Pichia-produced IgG 2C2 variants. (f ) Thermal denaturation curves of Pichia-produced IgG 6B3 variants.
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The increased stability of the M variant over its WT coun-
terpart was further investigated with respect to
denaturant-induced unfolding. For this purpose, antibody
molecules were incubated in various concentrations of
GdnHCl and analyzed by ITF after an overnight incubation
(Fig. 5). To better identify the signals derived from unfolding
of the CH2 domains, glycan knock-out T299A mutants were
also examined (data not shown). Previous studies (Schaefer
Fig. 4. Biophysical characterization of IgG and Fab constructs produced in mammalian cells by ITF. (a) Thermal denaturation curves measured by ITF. The
curves were obtained from the intensity ratio of the emission spectrum at 330 nm (F330) and 350 nm (F350) upon excitation at 295 nm, plotted as a function of
temperature. A comparison between the different mammalian IgG 2C2 (continuous lines) and Fab 2C2 (dotted lines) variants is shown. (b) Thermal
denaturation curves of IgG 6B3 and Fab 6B3 measured analogously to the method used in panel (a). (c) ITF analysis of HEK IgG 2C2 in the presence of 1 M
GdnHCl (d) pH dependence of thermal denaturation. The midpoints of the denaturation curves for HEK IgG 6B3 WT and M were determined at various pH
and plotted as a function of pH.
Fig. 5. GdnHCl-induced denaturation of IgGs expressed in mammalian cells. The denaturation of various antibody variants was followed by plotting the F330/
F350 ratio as a function of increasing GdnHCl concentration for (a) HEK IgG 2C2, (b) HEK IgG 6B3 and (c) HEK Fab 6B3.
J.V.Schaefer and A.Plu¨ckthun
494
and Plu¨ckthun, 2012) had clearly shown a decreased CH2 sta-
bility for unglycosylated IgGs, and thus, the first transition
e.g. at 2 M GdnHCl in Fig. 5a could be assigned to CH2, as
it shifted to even lower GdnHCl in the glycan knock-out
mutant (data not shown). Thus, the second transition of the
unfolding curves could be assigned to the Fab fragment.
For all analyzed antibody variants, the introduced muta-
tions caused an increased stability compared with the re-
spective WT. Whereas the transition due to the Fab fragment
was detected in the WT variants of the 6B3 and 2C2 con-
structs at 2.0 and 2.5 M GdnHCl, the engineered mutants
showed an increased Fab stability of 2.6 and 3.8 M, respect-
ively. The same results were also obtained when the Fab 6B3
fragments were analyzed by themselves, i.e. as a produced
Fab fragment (Fig. 5c). In addition to the differences in equi-
librium stability, the kinetics of unfolding was considerably
different between M and WT for some conditions and thus
amplified the stability differences, as illustrated in time-
dependent unfolding studies displayed in Supplementary
Data Fig. S4. Although resulting in the same signal after an
overnight incubation, the presence of, e.g. 4.5 M GdnHCl
was sufficient to denature the 2C2 WT variant completely
within 10 min while IgG 2C2 M was not fully unfolded in
the same GdnHCl concentration even after 2 h. Analogous
results were obtained for the 6B3 constructs in the presence
of, e.g. 3.5 M of denaturant.
Analysis of the antibody molecules on the domain level
Finally, we aimed to investigate the effect of the VH muta-
tions within the antibody at the level of individual domains
or interacting folding units. The methods of choice for these
studies are DSC or DSF. DSF has the advantage of small
sample requirements and easy sample preparation, making it
suitable for high-throughput applications and initial screens.
However, the nature of transitions is much more difficult to
assign, and changes in later transitions (i.e. more stable
domains) are more difficult to detect. For IgGs, the transition
of the CH2 unfolding detected at 728C emerged to be the
Fig. 6. Characterization of HEK-produced antibodies by DSF. Comparison of normalized DSF signals of HEK-produced antibody WT (blue) and M (red)
variants. For the IgGs, the transition of the CH2 unfolding is the dominant signal detected. DSF spectra were recorded for (a) IgG 2C2 and (b) IgG 6B3. For
an easier comparison, the corresponding normalized first derivatives (dF/dt) of the signals in (a) and (b) are shown in (c) for IgG 2C2 and in (d) for IgG 6B3.
The dF/dt graphs for the corresponding Fab-fragments are depicted in (e) for Fab 2C2 and in (f ) for Fab 6B3.
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most dominant signal, making the detection of later transi-
tions involving the most relevant part of the molecule, the
Fab fragment, quite difficult or even impossible (Fig. 6).
Although the transition of a second domain could still be
clearly seen for the 6B3 construct (74.58C vs. 778C for WT
and M variants, respectively, as depicted in Fig. 6b), DSF
showed apparent limitations in the analysis of Fab fragments
with very high stabilities. In the 2C2 variants only slight dif-
ferences were detectable at 848C in Fig. 6a. For compari-
son, also the corresponding first derivatives (dF/dt) were
plotted in Fig. 6c and d, highlighting again the differences in
the second domain transition for the 6B3 IgGs (73.88C vs.
76.38C). These signals could be definitely attributed to the
corresponding Fab domains, as they matched the data
obtained from the corresponding recombinant Fab fragments
(Fig. 6e and f). For the 6B3 Fab variants, the transitions
were determined to be 72.88C or 77.38C and thus 4.58C
apart.
As DSF proved to be limited in its analytical potential of
domains with much higher stabilities than the first transition,
antibody samples were also subjected to DSC analysis
(Fig. 7). These analyses require more time and sample, but
can resolve three major transitions originating from the CH2,
CH3 and Fab fragments, as is typically seen for IgG (Garber
and Demarest, 2007). Yet for most of our samples, some of
these peaks were overlapping. However, combining the
results from both 2C2 and 6B3 constructs as well as from the
T299A glycan knock-out mutants with their lowered CH2
stability (Fig. 7e), clear assignments could be made.
Whereas the transitions of the glycosylated CH2 and of the
CH3 domains were detected at 70.18C or 81.38C, respective-
ly, the signals of the different WT and M Fab fragments
were found between 708C and 888C for the 6B3 and 2C2
construct.
In agreement with the results from the other analysis tech-
niques detailed above, the Fab fragment of the engineered
6B3 M variant was of higher stability than its WT counter-
part (on average 2.58C). This could be detected for the IgGs
produced in HEK (Fig. 7b), in Pichia (Fig. 7d) as well as for
the HEK-produced Fab fragments (Fig. 7f). Interestingly, for
Fig. 7. Analysis of IgG domain stability by DSC. Signals derived from WT variants are shown in blue while those of the mutant M are represented in red.
DSC curves were recorded for (a) HEK IgG 2C2, (b) HEK IgG 6B3, (c) PP IgG 2C2, (d) PP IgG 6B3, (e) HEK IgG 6B3 T299A and (f ) HEK Fab 6B3.
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the first time also small differences in the thermodynamic
stability could be demonstrated for the 2C2 Fab construct
(Fig. 7a and c). The signals of the mutated Fab fragments
showed a melting temperature which was 1.88C higher
than that of the WT variants and this difference was found
for IgGs expressed in either the HEK or Pichia system, re-
spectively. A comparison of the DSF and DSC derived data
is presented in Supplementary Data Fig. S5.
Electrophoretic analyses of various IgG variants
When full-length IgGs were run on a gradient gel under non-
reducing conditions and without prior heating (Fig. 8a), clear
differences for the WT and M variants were encountered.
Independent of whether the IgGs had been purified from
HEK or Pichia cultures, WT IgGs usually could not be
detected as a clear band at the corresponding size of
150 kDa, but rather as a smear or overlay of several individ-
ual bands. In contrast, the M variant gave rise to one clear
and distinct band on Coomassie-stained gels (especially the
6B3 constructs, shown on the right side of the gel in
Fig. 8a). To investigate this peculiar difference in running
behavior between WT and M versions of the IgGs in more
detail and at greater resolution, the same samples were run
under identical conditions on low-percentage (7.5%) SDS
polyacrylamide gels (Fig. 8b). Again, the engineered mutants
could be detected as one distinct band, while for the WT
variant several bands became visible. Interestingly, all these
WT bands ran at slightly higher apparent molecular weights
than the M counterparts—a feature that could be observed in-
dependent of whether the IgGs have been purified from
stable HEK or Pichia cells.
To ensure that these differences between WT and M were
not caused by effects of protein purification or storage, we
also analyzed the non-processed supernatants of Chinese
hamster ovary cells after transient transfection (CHOt) and
compared it to that of HEK293 cells after transient (HEKt)
or stable (HEKs) transfection, respectively. As can be seen in
Fig. 8c, the same banding patterns were observed in all cases
and further confirmed for the yeast system as well (data not
shown). To ensure that the differences in the running behav-
ior were not caused by variations in the glycan moiety
attached to the CH2 domain of the IgG, antibodies with the
glycan knock-out T299A mutation were also analyzed by
SDS-PAGE. Whereas as expected, the unglycosylated IgGs
ran generally at slightly lower apparent molecular weights,
the banding pattern was not altered (Fig. 8d).
To test for covalent heterogeneities, we subsequently per-
formed IEF analyses. In this method, the samples were
Fig. 8. Analysis of running behavior of IgGs on SDS-PAGE and IEF. (a) SDS-PAGE of equal amounts of the Protein A-purified HEK and Pichia constructs
stained with Coomassie Blue. Samples were run under non-reducing conditions without heating prior to loading onto NuPAGE gradient gels. (b) SDS-PAGE
analysis of the same samples as in panel (a) run on a low-percentage (7.5%) gel under the same, non-reducing conditions. (c) Western blot analysis of IgG
variants detected with antibodies specific for the respective light chains. Samples were obtained from the supernatant of Chinese hamster ovary cells after
transient transfection (CHOt) and from HEK293 cells after transient (HEKt) or stable (HEKs) transfection, respectively. (d) Comparison of HEK IgG variants
to their non-glycosylated counterparts (T299A glycan knock-outs) by non-reducing SDS-PAGE. (e) Isoelectric focusing of HEK-produced 6B3 variants.
Non-reduced IgG, IgG T299A and Fab were separated based on their pI. A pI standard is shown in the right lane, with the corresponding pI values denoted
next to it.
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neither heated nor modified but just analyzed on pH gradient
IEF gels. As the pIs of the 2C2 constructs were rather high
(Fig. 1b), only the 6B3 constructs could be analyzed by IEF.
As shown in Fig. 8e, all 6B3 constructs (IgG, IgG T299A as
well as the Fab fragments) were focused in single major
bands at positions of the gel corresponding to their pI, indi-
cating that charge heterogeneity in the molecules was not the
reason for the different running behavior on SDS-PAGE. The
homogeneity of the samples was also confirmed by mass
spectroscopy after prior reduction (data not shown), and is
consistent with reducing SDS-PAGE (Fig. 1c) where no dif-
ferences in the IgG chains between WT and M had been
detected.
To further elucidate the reasons for the different running
behaviors of the IgG variants, samples were once more
studied by non-reducing SDS-PAGE (Fig. 9). This time,
however, the samples were partly heated for 5 min at 958C or
alkylated prior to loading. Whereas the heating of the sample
to 958C eliminated the different running behavior of the var-
iants (Fig. 9a), alkylation of samples by three different alkyl-
ation reagents did not change these characteristics (Fig. 9b).
We next considered the possibility that in the WT variants
one or more disulfides might not have formed correctly and
thus the molecules could have undergone disulfide shuffling,
facilitated by sample heating. Previous studies showed that
multiple bands for IgG samples on SDS-PAGE in principle
can also arise from loss of disulfide-linked chains after disul-
fide scrambling (Liu et al., 2007). Therefore, we wished to
elucidate whether the different individual bands seen for the
WT variants consisted of distinct covalent isoforms or
whether all these bands were in equilibrium. For this reason,
IgG 2C2 WT was run on a regular non-reducing 7.5%
SDS-gel (after incubation in the absence or presence of al-
kylation reagent) and afterwards analyzed by a non-reducing
second SDS-PAGE in a perpendicular orientation (see
Fig. 9c and d and Materials and Methods for details). The
silver-stained bands clearly indicated that the molecules
found in each of the various individual bands in the first di-
mension differentiated again in the second dimension and
gave rise to the usual banding pattern, independent of
whether the samples had been alkylated beforehand or not.
This finding would not be consistent with disulfide shuffling.
To test more rigorously whether the distinct bands of the
WT are really in equilibrium, distinct bands of the WT and
M variants were cut from the first gel and placed into the
pockets of the second one (Fig. 9e). Again, the previously
distinct bands re-divided into the original banding pattern.
Due to the increased sensitivity of the silver staining proced-
ure, even small amounts of the higher molecular weight
bands could be detected for the M variant under these condi-
tions. We thus can rule out disulfide shuffling as the source
of the multiple bands detected for the WT IgG.
Fig. 9. One- and two-dimensional SDS-PAGE analysis of the different running behavior of WT and M variants. (a) Analysis of non-reduced IgG samples.
Shown are the banding patterns of various IgG constructs after incubation in SDS-loading buffer at either room temperature or 958C for 5 min prior to loading.
(b) Influence of alkylation on banding patterns. IgG 2C2 samples were incubated with a 50-fold molar excess of N-ethylmaleimide (NEM), iodoacetamide
(IAA) or iodoacetic acid (IA-A) in 100 mM Tris pH 8 (pH 7 for NEM) at 378C for 3 h prior to analysis by non-reducing SDS-PAGE. (c) 2D-SDS-PAGE
analysis of HEK IgG 2C2 WT. After the samples had been separated by regular non-reducing SDS-PAGE (shown on top, corresponding to the sample run on
lane 1 of the gel depicted in panel (a)), the corresponding lane was isolated and re-run on a second SDS-PAGE in a perpendicular orientation. The final gel
was silver-stained. (d) 2D-SDS-PAGE of the same sample as in panel (c). However, prior to the first SDS-PAGE, the sample was incubated in the presence of
5 mM NEM for 1 h. (e) 2D-SDS-PAGE of HEK IgG 2C2 WT and M. The bands were individually cut out from a first gel, as depicted in the inlay, and run in
separate lanes on the second gel (corresponding to the band numbers in the first gel), and the gel was silver-stained.
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Although both in this study and the one reported previous-
ly (Liu et al., 2007) multiple bands of IgG have been seen
under non-reducing conditions, there are important differ-
ences pointing to a different origin of the phenomena. Most
importantly, in the experiments reported here the multiple
bands disappear when the samples are heated to 958C
(Fig. 9a), while Liu et al. observed an increase of the
banding pattern (i.e. more of the faster running bands) after
prolonged heating and at high pH. Furthermore, in the
re-equilibration experiments described above (Fig. 9c–e), all
bands can be generated from all other bands (Fig. 9e), while
Liu et al. observed an irreversible increase of smaller bands,
consistent with a loss of chains from the H2L2 molecule. We
therefore propose that the phenomena seen here are due to
conformational rearrangements and precede any chain loss
due to disulfide scrambling or progressive b-elimination (Liu
et al., 2007). This is consistent with the western blots, which
indicate the presence of both chains in the high MW bands
in Fig. 9, and the generation of a 100-kD band (representing
H2) only after prolonged mild reduction (see below). In
summary, the conformational changes seen here are happen-
ing under much milder conditions than the chain loss
described previously (Liu et al., 2007) and represent con-
formational transitions of the intact IgG.
Capillary electrophoresis
To finally exclude that any particular effect of SDS-PAGE
itself was causing the multiple band behavior, we also
analyzed IgG samples by capillary electrophoresis. In this
setup, the detection of the proteins was achieved using SDS
micelles containing a provided fluorescent dye (Chen et al.,
2008). Upon binding to hydrophobic regions on the analyzed
proteins, these SDS–dye complexes are protected from disas-
sembly in the performed dilution step, generating a fluores-
cent signal clearly above background.
Also in this setup, multiple signals could be detected for
the non-reduced, non-heated WT variants, as depicted for the
IgG 6B3 WT in lane 1 in Fig. 10a and for IgG 2C2 WT in
Fig. 10b. Strikingly, the M variants were not detectable at all
under these conditions (lane 2 in Fig. 10a). Only once they
had either been heated and/or reduced, equimolar amounts of
the loaded M-type became visible in the corresponding chro-
matograms (Fig. 10c and d). Thus, the inability to detect the
M variant under the initial conditions was not caused by too
low IgG amounts loaded onto the chip, but rather hinted at a
higher stability or improved folding of this molecule, pre-
venting access to hydrophobic regions by the fluorescent dye
used for detection in capillary electrophoresis. Thus, it did
not bind to the native M protein, but only to the WT.
Partial reduction of IgG variants indicates differences
in conformational stability
As these results indicated differences in the structural stabil-
ity of the non-reduced, non-heated antibody molecules
between their WT and M form, we analyzed HEK-produced
IgGs by partial reduction. For this purpose, samples were
Fig. 10. Analysis of HEK IgGs by capillary electrophoresis. (a) HEK IgG 6B3 WT and M variants were analyzed in the absence or presence of reducing
agent upon incubation in the loading buffer either at 25 or 758C (presented as a virtual gel). The same data are presented as chromatograms in panels (c) and
(d). (b) Chromatogram of HEK IgG 2C2 WT, illustrating the occurrence of similar differences in the banding pattern as detected by SDS-PAGE. (c)
Chromatograms of IgG 6B3 samples analyzed under non-reducing conditions. H2L2 indicates the completely assembled IgG. (d) Chromatograms of the same
samples as in (c), analyzed after incubation in the presence of DTT. H2 indicates a heavy chain dimer and H or L the monomeric heavy or light chain
molecules, respectively.
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shortly incubated in the presence of the strongly reducing
TCEP without any further heating prior to loading onto
SDS-gels. We reasoned that the hydrophilic nature of TCEP
should not allow it to easily penetrate into the hydrophobic
cores of the IgG domains where the intradomain disulfides
are located, without prior partial unfolding of the domains.
Therefore, such partial reduction experiments represent an in-
dicator for the compactness of these domains as well as the
packing of the VH–VL interface.
As depicted in the Coomassie-stained gel and the corre-
sponding anti-light chain western blot in Fig. 11a and b, re-
spectively, incubation of the samples in the presence of
TCEP seemed to disrupt the disulfide bond between the light
and the heavy chain for both the 6B3 and the 2C2 constructs.
Interestingly, a much more dramatic effect was observed for
the WT constructs than for the M variants. Whereas IgG
molecules containing a light chain could still be detected for
both 6B3 constructs after TCEP reduction, all the HEK IgG
2C2 WT molecules were converted into homo-dimers of the
heavy chain only (H2 molecules running at 100 kDa), com-
pletely lacking the light chains and therefore not being de-
tectable in Fig. 11b, but only on the Coomassie-stained gel
in Fig. 11a.
To confirm this observation, partly reduced 2C2 samples
were treated with 5-IAF to fluorescently label free cysteine
residues. Samples were incubated with very low TCEP
concentrations, corresponding to only 2–10-fold molar
equivalents, as higher concentrations were found to interfere
with the subsequent 5-IAF coupling. Still, clear differences
could be seen in the fluorescent images of non-reducing and
reducing gels (Fig. 11c and d, top gels). Only the WT
variant was labeled quantitatively at 2 molar equivalents and
to a much higher extent at 10 conditions. Beneath the
fluorescent images, the corresponding Coomassie-stained
gels confirm that equal antibody amounts were loaded on the
gels. Especially after overnight labeling with a 5-fold molar
excess (Fig. 11e), the difference between WT and M variants
became clearly visible, as the WT variant was labeled both
on its heavy and light chain, while no fluorescence was de-
tectable for the M counterpart.
Taken together, these data suggest that the introduced vari-
able domain mutations, all located within VH, affected the
packing of the VH–VL and CH1–CL interface and thus pro-
tected the intermolecular disulfide bond. It is likely that this
improved structural integrity potentially also contributed to
the increased stability of the engineered M variants as a
whole IgG molecule.
Discussion
The aim of this study was to analyze whether sequence en-
gineering, previously found capable of considerably
Fig. 11. Partial reduction of antibody variants. (a) Non-reducing SDS-PAGE of HEK constructs stained with Coomassie Blue. Samples were incubated in the
absence or presence of 30 mM TCEP for 10 min at 258C prior to loading. (b) Western blot analysis of the same samples as in panel (a) detected with an
antibody mixture specific for both light chains. (c) Non-reducing SDS-PAGE of partially reduced HEK IgG 2C2 variants labeled with 5-IAF. Samples were
incubated in the absence or presence of the stated molar equivalent of TCEP for 1 h at room temperature prior to labeling with a 5-fold molar excess of 5-IAF
for 2 h. The upper gel shows the fluorescence image, the lower picture the same gel after staining with Coomassie Blue. (d) Images of the same samples as in
(c) run under reducing conditions. (e) Comparison of WT and M variants reduced by 2 molar equivalents of TCEP for 1 h prior to labeling with a 5-fold molar
excess of 5-IAF overnight. The upper gel shows the fluorescence image of a reducing gel, the lower one the Coomassie-stained gel.
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improving the biophysical properties of antibodies as scFv
fragments (Wo¨rn and Plu¨ckthun, 2001), would have a similar
effect on whole antibodies in the IgG format. The original
work was carried out in single domains and smaller assem-
blies (Wo¨rn and Plu¨ckthun, 1998, 2001; Ewert et al., 2002;
Ewert et al., 2003a, Ewert et al., 2003b; Monsellier and
Bedouelle, 2006) as the extremely complex unfolding mech-
anism of IgGs (Buchner et al., 1991; Vermeer and Norde,
2000; Feige et al., 2010) with their 12 immunoglobulin
domains interacting with each other would have made an elu-
cidation of individual domain contributions and mutations
impossible to untangle in the context of the whole antibody.
Despite the appeal of our previous reductionist approach,
it was not clear a priori, whether the previous findings
would be transferable from the scFv to the IgG format. It
might be possible that the presence of the constant domains
of the Fab fragment, especially when linked via an intermo-
lecular CH1–CL disulfide bond (Ro¨thlisberger et al., 2005),
overcomes stability problems within the variable domains
themselves and/or at the VH/VL interface. Furthermore, the
previous experiments were carried out with antibody frag-
ments produced in functional form by secretion to the peri-
plasm of E. coli. As whole IgGs are predominantly secreted
from eukaryotic cells (although functional expression of IgG
in E. coli has been reported as well; Simmons et al., 2002;
Mazor et al., 2009; Makino et al., 2011), it had to be investi-
gated how the eukaryotic quality control system influences
both the level and the properties of the resulting molecules,
and whether it would be able to somehow compensate for
the previously observed differences.
Thus, in this study we aimed to address these questions on
two levels: first, the biophysical properties of the resulting
proteins in isolation, and second, the influence of the expres-
sion systems used. To tackle these questions, we made use of
an exceptionally well-characterized set of mutants (Ewert
et al., 2003a), where prior knowledge for each individual
substitution (see Introduction) regarding their effect on
thermodynamic stability or folding efficiency was available,
measured by functional expression in E. coli. As an inter-
mediate between scFv and IgG, we also constructed recom-
binant Fab fragments. To ensure meaningful results
regarding the eukaryotic expression levels, we used homolo-
gous recombination into the same chromosomal location of
the host cells as well as constitutive promoters for both the
Pichia and HEK293 system.
Influence of the expression system
Unlike scFv produced in the bacterial periplasm, IgGs and
Fab fragments expressed in both eukaryotic systems did not
show any significant differences in their secretion yields
found in the respective supernatants (Fig. 2). We also
ensured that almost all of the antibody amounts synthesized
by the cells were secreted (Supplementary Data Fig. S1a),
excluding a bottleneck in secretion. Thus, these results
derived from HEK and Pichia expression indicate that the
eukaryotic secretory quality control system equalizes the ex-
pression yields of the WT and stabilized VH6 variants, inde-
pendent of the antibody format used. Interestingly, the
leveling of expression yields is only partial in Pichia (with
the stabilized mutants still producing slightly more antibody)
but almost complete in the mammalian cells. Similar results
had been previously obtained when engineered anti-tetanus
toxoid Fab fragments were converted into the IgG format
(Demarest et al., 2006). Also for these Fab molecules the
differences in the expression levels seen upon production in
E. coli were not reflected in different levels of IgG found in
mammalian expression.
We could show that the equalized expression levels
are due to the eukaryotic host, and not the used IgG or Fab
format. When comparing the periplasmic expression
levels of full-length IgG in E. coli, we found the same
increased expression levels for the engineered IgG molecules
compared with WT as for the engineered scFv in E. coli
(Supplementary Data Fig. S1b). However, as the expression
levels of correctly assembled IgGs were generally low, no
quantitative ELISAs could be performed, and these findings
had to be obtained from western blot analysis.
Taken together, all these data indicate that stability engin-
eering can improve bacterial expression and secretion of
functional antibodies in all formats tested—single domain
scFv, Fab, up to intact IgG—by mutations that prevent aggre-
gation during periplasmic folding (Knappik and Plu¨ckthun,
1995; Nieba et al., 1997; Ewert et al., 2002, 2003a; Demarest
et al., 2006). However, the eukaryotic quality control can
‘rescue’ such aggregation-prone IgGs and secrete them at
comparable level as the engineered mutants.
Analysis of biophysical properties of WT and M
To analyze whether the previously found improvements of
the biophysical properties stayed true for various antibody
formats produced in eukaryotic systems, sufficient quantities
of the corresponding antibodies could be purified and ana-
lyzed (1–2 mg/l from Pichia, 4–8 mg/l from HEK293 cells),
even though the constitutive expression systems were chosen
for consistency, and not maximal yields.
Increased stabilities of the engineered IgGs (M variants)
were observed by all analysis methods (Figs 3–7). The data
derived from thermal denaturation measured by ITF, DSF
and DSC as well as those from GdnHCl unfolding are sum-
marized in Supplementary Data Table S1 for the
HEK-produced IgG and Fab fragments. As the various
methods emphasize different factors, the results listed are
based on very different phenomena. Therefore, it is useful to
briefly summarize what they actually indicate. In general,
both CD and ITF measure averaged features of the whole
antibody molecule—either the overall secondary structure or
the averaged tryptophan fluorescence, respectively. In con-
trast, DSF and DSC have the ability, at least in principle, to
distinguish different transitions in multidomain proteins
(such as IgGs) which are averaged in the previously
described spectroscopic methods.
The midpoints of thermal denaturation determined with
CD and ITF were in quite good agreement with each other,
with the ITF-recorded temperatures being of slightly lower
values. Already at these lower temperatures, solvent may
start penetrating into the protein core and may thereby make
the environment of at least some tryptophans more hydro-
philic, while the overall secondary structure measured by CD
still is mainly intact. However, the increase in stability deter-
mined by both methods for HEK IgG 6B3 M over its WT
counterpart gave very similar DT results of 2.58 or 3.28C,
respectively. These stability improvements were also in good
agreement with the data recorded for the Fab fragments by
DSF and DSC, even though the measured absolute transition
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temperatures were of higher value, as the least stable CH2
domain is not present in the Fab fragment und thus not taken
into the average.
For IgGs, DSC analyses generally resulted in three distin-
guishable transitions, while in the DSF results often only the
transition of the CH2 unfolding could be clearly assigned
(for comparison, see Supplementary Data Fig. S5). This
finding can be explained by the fact that DSF measurements
are based on intensity changes of the fluorescence of the dye
SYPRO Orange as a function of its environment. Its fluores-
cence is weak in aqueous and hydrophilic environments, but
strongly increases upon binding to hydrophobic patches that
become accessible in denaturing proteins (Niesen et al.,
2007). After reaching a maximum, the signal decreases at
higher temperatures. This is most likely caused by precipita-
tion and aggregation of the analyzed protein, removing
SYPRO Orange binding sites from solution. Therefore, the
detection of high-temperature transitions, e.g. that of a very
stable Fab within the IgG, is very challenging or even
impossible.
In contrast, DSC measures the enthalpy of unfolding
(Bruylants et al., 2005) due to heat denaturation and thus
allows the individual detection of various transitions. The
DSC results clearly and directly confirmed the increased sta-
bilities of the engineered IgG 2C2 and 6B3 molecules and
could assign the effect, as expected, to the Fab fragment
within the IgG.
Interestingly, the gain in thermal stability caused by the in-
sertion of the six-point mutations was always higher in the
context of the isolated Fab fragments compared with the gain
recorded within the full-length IgGs. Not just the ITF data
revealed a change of 4.58C compared with only 3.28C for the
IgG molecule, but also the DSC data, allowing to clearly
point to a Fab transition, showed an increase of 48C for the
stabilized isolated Fab fragment and 2.28C for the Fab frag-
ment in the context of the M IgG (Fig. 7f). At the moment,
we have no definite explanation for this phenomenon, and
want to stress that these data are derived from irreversible
unfolding experiments, where the formation of aggregates
could potentially affect the recorded data. We cannot
exclude, however, that Fab unfolding might be influenced by
interactions with the Fc part of the IgG, or that kinetic bar-
riers are different for the Fab in isolation and within the
IgG—a hypothesis that has been discussed controversially
before (Kilar and Zavodszky, 1987; Lilie, 1997; Ionescu
et al., 2008).
Comparing the antibodies 2C2 and 6B3
The overall stabilities of the 2C2 and 6B3 constructs varied
significantly, with the 2C2 construct in its WT state being
already of quite high overall stability. Both antibodies differ
in their light chains, with 2C2 containing a k-light chain with
Vk3. This VL domain had been shown previously (Ewert
et al., 2003b) to be of considerably higher stability when
expressed individually than members of the Vl3 family,
which are present in the 6B3 construct. This difference in sta-
bility apparently stayed true in the context of single VL
domain, scFv, Fab and IgG, as shown in this study.
Thus, the two antibody constructs analyzed in this study
covered a broad range of stabilities, from rather unstable
(6B3 constructs) to extremely stable (2C2 constructs). This
allowed us to show not only that our engineering strategy
was successful in both cases, but also to evaluate analytical
methods for detecting the effect in a stable and unstable IgG
molecule. We found that most methods were unsuitable to
characterize the stability gain of 2C2 M vs. 2C2 WT. Only
for thermal denaturation measured by DSC as well as for
GdnHCl-induced unfolding, improved stability characteristics
of the 2C2 M molecules could be detected. For thermal
unfolding studied by ITF, conclusive data could only be
obtained in the presence of GdnHCl. For the 2C2 construct,
however, the increase in stability was less pronounced with
only 1.68C compared with 2.58C measured on average
for the 6B3 constructs.
In GdnHCl-induced unfolding, the engineered variant of
6B3 denatured at a GdnHCl concentration 0.6 M higher than
that of the WT counterpart, while this difference was
1.3 M for the 2C2 constructs. These data could also be
confirmed by the analysis of the glycan knock-out T299A
mutants (data not shown) and the individual Fab fragments.
This difference in stability gain seems puzzling at first, as in
thermal stability (measured by a variety of techniques) the
impact of the mutations was more pronounced for the 6B3
constructs. However, we must consider two aspects, one
regarding the measurements, the other regarding the denatur-
ant: first, the unfolding of a multi-domain protein followed
by ITF is very difficult to untangle in either temperature- or
denaturant-induced unfolding, as the transitions are not sepa-
rated and an intramolecular or intermolecular association of
partially unfolded domains will influence tryptophan fluores-
cence. Second, GdnHCl may prevent such association of par-
tially unfolded domains. Furthermore, the high ionic strength
of concentrated GdnHCl may modulate electrostatic contribu-
tions during the unfolding. The two analyzed antibody con-
structs 2C2 and 6B3 possess rather different pI values and
thus differ in their charge at any given pH. For these reasons,
thermal unfolding may not necessarily be mirrored in
GdnHCl unfolding (Monera et al., 1994).
Although increased stabilities against thermal and
denaturant-induced unfolding were also detected for M var-
iants upon expression in Pichia (Fig. 3f or Fig. 7c and d),
the melting points of IgGs produced in this system were gen-
erally lower than for the same IgG produced in mammalian
cells. These different stabilities could be pinpointed to the
CH2 domains and proven to be caused by different glycan
moieties, as described in detail elsewhere (Schaefer and
Plu¨ckthun, 2012).
Inhomogeneity of WT but not M in SDS-PAGE
We noticed a consistent ladder formation of WT IgGs on non-
reducing SDS-PAGE, whereas the mutants engineered for sta-
bility showed the expected unique band corresponding to a
molecular weight of 150 kDa (Fig. 8a and b). Interestingly,
also some commercially available antibodies like Omnitargw
(Pertuzumab, Genentech) showed similar banding patterns in
our analyses (data not shown). Proteolysis could be ruled out
as a cause considering the results from reducing SDS-PAGE
(Fig. 1c). Similarly, heterogeneity of the glycan structure
could be excluded by both IEF analysis (Fig. 8e) and the fact
that the multiple band pattern was preserved in non-
glycosylated T299A mutants (Fig. 8d).
We thus focused our attention on disulfide heterogeneities
and/or scrambling, a problem reported to occur for some
IgG4 molecules (Taylor et al., 2006). Yet, alkylation of the
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samples prior to loading did not affect the running behavior
of the IgG (Fig. 9b). Thus, if different disulfide bond linkages
were the reason for the detected phenotypes, they must have
been already present in the purified samples. Such observa-
tions had been reported previously for a member of the IgG2
family (Wypych et al., 2008). To test this possibility, we
devised a non-conventional 2D-SDS-PAGE (Fig. 9c–e), in
which non-reducing SDS-PAGE was carried out in both
dimensions. In this setup, whole lanes or single bands were
cut out and re-applied to a new gel. These experiments
showed that the different bands could not be separated from
each other but re-equilibrated in the second dimension, inde-
pendent of whether the samples had been previously alky-
lated or not. We thus can conclude that the multiple bands
are not due to disulfide heterogeneity.
This conclusion was further confirmed both by the analysis
of unpaired cysteines within the IgG molecules as well as by
mass spectrometry (MS) measurement. Quantification of free
thiols by the method using sodium borohydride and 4,40-
dithiodipyridine described by Hansen et al. (2007) did not in-
dicate any detectable free sulfhydryl groups for the WT and
M variants (data not shown), even though this had been
detected in other IgG molecules (Zhang and Czupryn, 2002).
In addition, analyzing the disulfide patterns of enzymatically
fragmented variants using liquid chromatography-mass spec-
trometry coupled to a combination of collision-induced dis-
sociation and electron-transfer dissociation fragmentation
(Wang et al., 2011) did not provide any indications that
wrong disulfide connectivities were present in any of the IgG
variants (data not shown).
Stability probed by dye binding
Stabilized mutants and WT IgGs could be further distin-
guished by their accessibility either to a fluorescent dye from
SDS micelles or to reducing agents. In capillary electrophor-
esis, which relies on detection of the proteins with SDS
micelles containing a provided fluorescent dye (Chen et al.,
2008), the IgG WT, but not the M variant could be observed
under non-reducing, non-heated conditions (Fig. 10).
However, after heating and/or reduction both variants were
equally well detected. These results could not be merely
attributed to the very slightly increased hydrophobicity of the
M variant, as it was increased only by one amino acid.
Therefore, these results rather indicated that the engineered
M-type IgGs are more densely packed and, consequently, less
label-containing SDS micelles can bind to or penetrate into
their structure.
These capillary electrophoresis experiments have some
similarity to DSF analyses. However, whereas in DSF experi-
ment the IgG is heated and the binding of the SYPRO
Orange dye is followed as a function of temperature, capil-
lary electrophoresis is isothermal and thus can be carried out
below the denaturation temperature. At this temperature, SDS
seems to allow access of the dye only to the WT, but not to
the stabilized mutant. This is remarkable, as the DSC experi-
ments showed that the CH2 domains denatured first, and
these domains are identical for WT and M. Thus, the signifi-
cant differences detected for M and WT variants in the capil-
lary electrophoresis experiment must be due to the dye’s
accessibility to binding sites within the Fab fragment.
Stability probed by partial reduction
Intermediates in the denaturation and reduction of IgGs have
been monitored before, both by SDS-PAGE and by capillary
electrophoresis (Alexander and Hughes, 1995; Brody, 1997).
However, we believe that this study is the first to compare
point mutants in the IgG format using these techniques. In
partial reduction experiments with TCEP, clear differences in
the accessibility of the inter-chain H–L disulfide bond could
be detected. The WT variants, but not their M counterparts
were losing their light chains (which were identical in both
mutants) either to a large extent or completely, as confirmed
by both western blot analysis and fluorescent labeling of the
liberated thiol groups. This finding was rather astonishing, as
all introduced mutations are located within the VH domain,
while the disulfide bond connects the distal ends of CH1 and
CL. Thus, these data suggest a weakening of the H/L inter-
face which is felt throughout the whole Fab fragment.
Taken together, these results support our assumption that
the performed mutations do not just influence the stability of
the resulting IgGs in the domain where the mutations are
localized (VH), but also a domain distal to it thus affecting
the overall integrity and structural homogeneity of the IgG
molecules. It is well established that IgG domains other than
the CH2 (due to its glycosylation) interact strongly in a
lateral fashion, forming VH–VL, CL–CH1 and CH3–CH3
modules, respectively (Ro¨thlisberger et al., 2005). In contrast
to these strong lateral interactions, longitudinal interactions
generally are reported to be rather weak or even nonexistent.
Nevertheless, the ball and socket joints between the VH and
CH1 or VL and CL domains, respectively, combined with
some movement within the VH–VL interface provide some
structural variation to the Fab fragment (Lesk and Chothia,
1988) that could partially explain the detected results.
Whether, however, structural changes within the Fab frag-
ment can be transmitted to the constant domains within the
Fc part has been controversially discussed for a long time
(Simon and Rajewsky, 1990; Pritsch et al., 1996; Morrison
et al., 1998; Chan et al., 2004; Ro¨thlisberger et al., 2005).
Our results do not indicate such interactions in the native
molecule, and the observations may be explained without
postulating them. Mutations within the VH domain could
affect the VH–VL interface, which by the coupling within
the Fab fragment (Ro¨thlisberger et al., 2005) could lead to
the observed facilitated reduction of the CH1–CL disulfide.
Antibodies having lost their light chains may subsequently
show a different susceptibility to reducing agents in the
hinge region and other domains in the Fc part. As a corol-
lary, we can consider the variable domains as a potentially
weak link, and the engineering of this domain can make a
decisive improvement in stability—even for the whole IgG
molecule, as shown by this study.
Conclusions
Taken together, the present data clearly indicate that the muta-
tions introduced into the VH6 framework have beneficial
effects not just in the scFv context but also in the IgG format.
Although an increase in expression levels was only detectable
for periplasmic expression in E. coli, increased stabilities both
with respect to thermal and denaturant-induced unfolding of
both Fab fragments and full-length IgG were seen,
Stabilizing mutations in IgG and Ab fragments
503
independently of the expression host. These mutations proved
to be beneficial independent of the nature of the light chain
and could be applied to IgGs of rather distinct characteristics
concerning their pI values and Fab stabilities. The mutations
also influenced the structural integrity and homogeneity of the
engineered IgG molecules independently of any wrong disul-
fide bond connectivity. Presumably through an improved VH–
VL packing, the reduction of the intermolecular CH1–CL di-
sulfide was greatly slowed down in the stabilized variant.
These results confirm the potential of structure-based protein
engineering in the context of full-length IgGs and the transfer-
ability of improvements discovered in a systematic study of
smaller antibody fragments. Furthermore, it refocusses the en-
gineering of intact antibodies to the variable regions, while in
recent years it has mostly been concentrated on the constant
Fc part.
Supplementary data
Supplementary data are available at PEDS online.
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